|
|
|
|
|
|
|
|
CONCLUSIONS: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients. We also demonstrate the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.